Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 3013

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.19, p 0.623). This receipt's hash covers every field on it, plus the hash of receipt 3012, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 3013
    19 Oct 2026, 10:27 UTC

    UNC5C

    oligodendrocytes, braak

    predictionUNC5C in oligodendrocytes tracks Braak Lewy-body stage

    registeredc7b3346b79a08831

    discovery+0.19 p=0.623 n=9

    replication+0.17 p=0.670 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.19, p 0.623)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    8e5a847adbd16c9f26354c9e…
    follows 67647c4fd096…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 3013: UNC5C in oligodendrocytes, braak

power
full sample +0.20 (p 0.418, n 18), 95% CI -0.29 to +0.61. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.25 (p 0.315, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.22 (p 0.379, n 18). could be the mix.
skeptic
leave-one-out range +0.10 to +0.36, sign flips 0; without severely affected donors +0.20 (p 0.418, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for UNC5C in oligodendrocytes.

case closed: nothing better to follow up.